Skip to main content
Aurobindo Pharma Limited (BOM: 524804)
India flag India · Delayed Price · Currency is INR
1,186.70
-16.00 (-1.33%)
At close: Jan 21, 2025

Aurobindo Pharma Revenue

Aurobindo Pharma had revenue of 77.96B INR in the quarter ending September 30, 2024, with 7.99% growth. This brings the company's revenue in the last twelve months to 302.95B, up 12.41% year-over-year. In the fiscal year ending March 31, 2024, Aurobindo Pharma had annual revenue of 290.02B with 16.68% growth.

Revenue (ttm)
302.95B
Revenue Growth
+12.41%
P/S Ratio
n/a
Revenue / Employee
11.65M
Employees
26,015
Market Cap
698.15B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024290.02B41.46B16.68%
Mar 31, 2023248.55B14.00B5.97%
Mar 31, 2022234.55B-13.19B-5.32%
Mar 31, 2021247.75B16.76B7.26%
Mar 31, 2020230.99B35.35B18.07%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reliance Industries 9,398.38B
Tata Consultancy Services 2,520.82B
HDFC Bank 2,761.06B
Bharti Airtel 1,554.78B
ICICI Bank 1,638.51B
Infosys 1,635.60B
State Bank of India 3,360.28B
ITC Limited 751.35B
Revenue Rankings

Aurobindo Pharma News

More News